Ana Paula Tagliari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Paula Tagliari has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Maurizio Taramasso
HerzZentrum Hirslanden Zurich, Zürich, Switzerland
9 shared publications - Adriano Nunes Kochi
Electrophysiology Department Hospital Mãe de Deus Porto Alegre Brazil
7 shared publications Eduardo Keller Saadi
7 shared publications- Eduardo Keller Saadi
UFRGS
6 shared publications Maurizio Taramasso
Clinic of Cardiac Surgery, HerzZentrum Hirslanden Zurich, 8008 Zurich, Switzerland
6 shared publications- Rodrigo Petersen Saadi
Cardiovascular Surgery, Hospital Mãe de Deus, Porto Alegre, Rio Grande do Sul, Brazil
6 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Elsevier in JACC: Case Reports
Percutaneous Mechanical Aspiration for Obstructive Mechanical Aortic Valve Thrombosis: A Bailout Strategy
- 31 October 2026
- Published by Elsevier in JACC: Case Reports
Open AccessPercutaneous Mechanical Aspiration for Obstructive Mechanical Aortic Valve Thrombosis: A Bailout Strategy
- Open Access
- 7 October 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (10)
Diretriz Brasileira de Valvopatias – 2026
Sumário […] Diretriz Brasileira de Valvopatias – 2026 Sumário […] Diretriz Brasileira de Valvopatias – 2026
- 7 October 2026
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 123 (10)
Open AccessDiretriz Brasileira de Valvopatias – 2026
Sumário […] Diretriz Brasileira de Valvopatias – 2026 Sumário […] Diretriz Brasileira de Valvopatias – 2026
- Open Access
- 30 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (39)
Looking Beyond the Annulus
- 30 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (39)
Open AccessLooking Beyond the Annulus
- Open Access
- 29 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (29)
When Routine Becomes Critical
- 29 July 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (29)
Open AccessWhen Routine Becomes Critical
- Open Access
- 24 June 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (16) , 2165-2191
Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall
- 24 June 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (16) , 2165-2191
Open AccessRedo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall
- Open Access
- 24 June 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (15) , 1999-2024
Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall
- 24 June 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (15) , 1999-2024
Open AccessRedo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall
- Open Access
- 29 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (11)
Ultrasound-guided vs. fluoro-guided axillary venous access for cardiac implantable electronic devices: a patient-based meta-analysis
Aims: The use of ultrasound (US)-guided venous puncture for cardiac pacing/defibrillation lead placement may minimize the risk of periprocedural complications and radiation exposure. However, none of the published studies have been sufficiently powered to recommend this approach as the standard of care. We compare the safety and efficacy of ultrasound-guided axillary venous puncture (US-AVP) vs. fluoroscopy-guided access for cardiac implantable electronic devices (CIEDs) by performing an individual patient data meta-analysis based on previously published studies. Methods and results: We conducted a thorough literature search encompassing longitudinal investigations (five randomized and one prospective studies) reporting data on X-ray-guided and US-AVP for CIED procedures. The primary endpoint was to compare the safety of the two techniques. Secondary endpoints included the success rate of each technique, the necessity of switching to alternative methods, the time needed to obtain venous access, X-ray exposure, and the occurrence of periprocedural complications. Six longitudinal eligible studies were identified including 700 patients (mean age 74.9 ± 12.1 years, 68.4% males). The two approaches for venous cannulation showed a similar success rate. The use of an X-ray-guided approach significantly increased the risk of inadvertent arterial punctures (OR: 2.15, 95% CI: 2.10–2.21, P = 0.003), after adjustment for potential confounders. Conversely, a US-AVP approach reduces time to vascular access, radiation exposure, and the number of attempts to vascular access. Conclusion: The US-AVP enhances safety by reducing radiation exposure and time to vascular access while maintaining a low rate of major complications compared to the X-ray-guided approach. Clinical trial registration: PROSPERO identifier: CRD42024539623.
- 29 October 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (11)
Open AccessUltrasound-guided vs. fluoro-guided axillary venous access for cardiac implantable electronic devices: a patient-based meta-analysis
Aims: The use of ultrasound (US)-guided venous puncture for cardiac pacing/defibrillation lead placement may minimize the risk of periprocedural complications and radiation exposure. However, none of the published studies have been sufficiently powered to recommend this approach as the standard of care. We compare the safety and efficacy of ultrasound-guided axillary venous puncture (US-AVP) vs. fluoroscopy-guided access for cardiac implantable electronic devices (CIEDs) by performing an individual patient data meta-analysis based on previously published studies. Methods and results: We conducted a thorough literature search encompassing longitudinal investigations (five randomized and one prospective studies) reporting data on X-ray-guided and US-AVP for CIED procedures. The primary endpoint was to compare the safety of the two techniques. Secondary endpoints included the success rate of each technique, the necessity of switching to alternative methods, the time needed to obtain venous access, X-ray exposure, and the occurrence of periprocedural complications. Six longitudinal eligible studies were identified including 700 patients (mean age 74.9 ± 12.1 years, 68.4% males). The two approaches for venous cannulation showed a similar success rate. The use of an X-ray-guided approach significantly increased the risk of inadvertent arterial punctures (OR: 2.15, 95% CI: 2.10–2.21, P = 0.003), after adjustment for potential confounders. Conversely, a US-AVP approach reduces time to vascular access, radiation exposure, and the number of attempts to vascular access. Conclusion: The US-AVP enhances safety by reducing radiation exposure and time to vascular access while maintaining a low rate of major complications compared to the X-ray-guided approach. Clinical trial registration: PROSPERO identifier: CRD42024539623.
- Open Access
- 14 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (20) , 6115
Updates in Structural Cardiovascular Interventions: Key Insights from Recent Studies
The year 2024 brought remarkable advancements and high-quality evidence to the field of cardiovascular interventions
- 14 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (20) , 6115
Open AccessUpdates in Structural Cardiovascular Interventions: Key Insights from Recent Studies
The year 2024 brought remarkable advancements and high-quality evidence to the field of cardiovascular interventions
- Open Access
- 21 May 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (5) , 180
Present and Future Surgical Options for Tricuspid Regurgitation
Tricuspid regurgitation, once considered a relatively benign condition, has now gathered significant attention due to new evidence showing its impact on both short- and long-term follow-up. While surgical intervention remains the established standard approach for treating severe tricuspid regurgitation, current guidelines provide Class I indication for intervention in only a limited set of scenarios. This review delves into the present and future perspectives of surgical tricuspid regurgitation management, examining aspects such as disease prognosis, surgical indications, outcomes, and a comprehensive overview of past and upcoming clinical trials.
- 21 May 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (5) , 180
Open AccessPresent and Future Surgical Options for Tricuspid Regurgitation
Tricuspid regurgitation, once considered a relatively benign condition, has now gathered significant attention due to new evidence showing its impact on both short- and long-term follow-up. While surgical intervention remains the established standard approach for treating severe tricuspid regurgitation, current guidelines provide Class I indication for intervention in only a limited set of scenarios. This review delves into the present and future perspectives of surgical tricuspid regurgitation management, examining aspects such as disease prognosis, surgical indications, outcomes, and a comprehensive overview of past and upcoming clinical trials.
- Open Access
- 11 August 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 22, 101974
TAV-in-TAV and Beyond
- 11 August 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 22, 101974
Open AccessTAV-in-TAV and Beyond